Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23472) 23472
Publication (1800) 1800
Newsletter (723) 723
Book Review (127) 127
Book Chapter (85) 85
Newspaper Article (73) 73
Dissertation (64) 64
Magazine Article (44) 44
Conference Proceeding (26) 26
Reference (11) 11
Book / eBook (8) 8
Data Set (3) 3
Trade Publication Article (3) 3
Paper (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (13591) 13591
bradykinin (12259) 12259
bradykinin - pharmacology (8740) 8740
male (7283) 7283
humans (6866) 6866
rats (6040) 6040
female (4293) 4293
pharmacology & pharmacy (3334) 3334
index medicus (2922) 2922
in vitro techniques (2507) 2507
bradykinin - analogs & derivatives (2173) 2173
biochemistry & molecular biology (2126) 2126
bradykinin - metabolism (2026) 2026
mice (1933) 1933
dose-response relationship, drug (1809) 1809
cells, cultured (1755) 1755
physiology (1752) 1752
blood pressure - drug effects (1665) 1665
guinea pigs (1505) 1505
rabbits (1441) 1441
adult (1398) 1398
peripheral vascular disease (1381) 1381
dogs (1365) 1365
research (1351) 1351
nitric oxide (1327) 1327
calcium - metabolism (1290) 1290
middle aged (1289) 1289
rats, sprague-dawley (1280) 1280
neurosciences (1246) 1246
cardiac & cardiovascular systems (1211) 1211
time factors (1167) 1167
rats, wistar (1163) 1163
inflammation (1107) 1107
nitric-oxide (1105) 1105
bradykinin - antagonists & inhibitors (1076) 1076
activation (1058) 1058
angiotensin-converting enzyme inhibitors - pharmacology (1055) 1055
acetylcholine - pharmacology (1042) 1042
endothelium (1029) 1029
histamine - pharmacology (1010) 1010
amino acid sequence (997) 997
receptors (982) 982
bradykinin - physiology (954) 954
kinetics (952) 952
receptor (952) 952
kinins (933) 933
endothelium, vascular - drug effects (923) 923
expression (914) 914
angiotensin (910) 910
hypertension (910) 910
immunology (899) 899
peptides (894) 894
vasodilation - drug effects (892) 892
cells (884) 884
rat (865) 865
bradykinin receptor antagonists (856) 856
muscle contraction - drug effects (851) 851
physiological aspects (839) 839
cell biology (834) 834
molecular sequence data (813) 813
angiotensin ii - pharmacology (802) 802
vasodilator agents - pharmacology (793) 793
analysis (787) 787
cattle (778) 778
enzyme inhibitors - pharmacology (771) 771
endothelium, vascular - metabolism (770) 770
indomethacin - pharmacology (764) 764
swine (741) 741
aged (737) 737
histamine (730) 730
receptor, bradykinin b2 (725) 725
inhibition (722) 722
cell line (718) 718
blood pressure (708) 708
release (706) 706
angiotensin-converting enzyme (703) 703
muscle, smooth - drug effects (699) 699
kallikrein (694) 694
bradykinin - administration & dosage (685) 685
research article (682) 682
serotonin - pharmacology (668) 668
bradykinin - blood (659) 659
acetylcholine (655) 655
rats, inbred strains (644) 644
nitric oxide - metabolism (639) 639
signal transduction (619) 619
pain (618) 618
endothelium, vascular - physiology (609) 609
receptors, bradykinin - metabolism (601) 601
cats (597) 597
disease models, animal (596) 596
muscle, smooth, vascular - drug effects (581) 581
calcium (576) 576
capillary permeability - drug effects (576) 576
drug synergism (559) 559
proteins (559) 559
responses (549) 549
enzymes (545) 545
mechanisms (532) 532
endothelial-cells (530) 530
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22657) 22657
Japanese (367) 367
German (348) 348
Russian (344) 344
French (318) 318
Italian (147) 147
Polish (59) 59
Chinese (54) 54
Spanish (51) 51
Portuguese (22) 22
Korean (14) 14
Romanian (12) 12
Dutch (9) 9
Hungarian (9) 9
Swedish (8) 8
Czech (7) 7
Bulgarian (5) 5
Slovak (5) 5
Ukrainian (5) 5
Turkish (3) 3
Danish (2) 2
Finnish (2) 2
Bosnian (1) 1
Croatian (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Bradykinin, kallidin, and kallikrein
: supplement
by Bhoola, K. D and Erdös, Ervin G
1979, ISBN 9780387093567, Volume 25. Bd., Suppl., 817
Kinins | Kallikrein | Bradykinin
Book
Details down arrow
2. Full Text Unnötige abdominelle Eingriffe bei Patienten mit hereditärem Angioödem
by Hahn, Janina and Hoess, Alisa and Friedrich, Daniel Thomas and Mayer, Benjamin and Schauf, Lucia and Hoffmann, Thomas K and Greve, Jens
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, ISSN 1610-0379, 12/2018, Volume 16, Issue 12, pp. 1443 - 1450
ZusammenfassungHintergrundDas hereditäre Angioödem (HAE) ist eine seltene genetische Erkrankung mit rezidivierenden Schwellungen der Schleimhäute und der Haut.... 
Bradykinin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
by L. M. Fredrik Leeb-Lundberg and Francois Marceau and Werner Müller-Esterl and Douglas J. Pettibone and Bruce L. Zuraw and Lund University and Lunds universitet and Drug Target Discovery
Pharmacological Reviews, ISSN 0031-6997, 03/2005, Volume 57, Issue 1, pp. 27 - 77
Kinins are proinflammatory peptides that mediate numerous vascular and pain responses to tissue injury. Two pharmacologically distinct kinin receptor subtypes... 
PROTEIN-KINASE-C | STREPTOZOTOCIN-DIABETIC RATS | SPONTANEOUSLY HYPERTENSIVE-RATS | NITRIC-OXIDE SYNTHASE | BRADYKININ B-2 RECEPTOR | HUMAN LUNG FIBROBLASTS | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | NF-KAPPA-B | INHIBITOR-RELATED COUGH | ANGIOTENSIN-CONVERTING-ENZYME | Receptor, Bradykinin B2 - agonists | Bradykinin B1 Receptor Antagonists | Molecular Biology | Signal Transduction | Receptors, Bradykinin - physiology | Humans | Receptors, Bradykinin - genetics | Structure-Activity Relationship | Bradykinin B2 Receptor Antagonists | Receptor, Bradykinin B1 - agonists | Animals | Receptors, Bradykinin - classification | Receptor, Bradykinin B2 - metabolism | Receptor, Bradykinin B1 - metabolism | Basic Medicine | Farmakologi och toxikologi | Medical and Health Sciences | Pharmacology and Toxicology | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Blockade of bradykinin receptor b1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema
by Austinat, Madeleine and Braeuninger, Stefan and Pesquero, João B and Brede, Marc and Bader, Michael and Stoll, Guido and Renné, Thomas and Kleinschnitz, Christoph
Stroke, ISSN 0039-2499, 01/2009, Volume 40, Issue 1, pp. 285 - 293
Background and Purpose-Brain edema is detrimental in ischemic stroke and its treatment options are limited. Kinins are proinflammatory peptides that are... 
Edema | Stroke | Inflammation | Bradykinin | Endothelin-1 | ANTAGONIST | edema | ARTERY OCCLUSION | INFLAMMATORY RESPONSES | B-1 RECEPTOR | bradykinin | TISSUE-DAMAGE | ISCHEMIA | EXPERIMENTAL STROKE | stroke | MICE LACKING | CLINICAL NEUROLOGY | inflammation | PERIPHERAL VASCULAR DISEASE | KININ B1 | endothelin-1 | EXPRESSION | Bradykinin - analogs & derivatives | Encephalitis - prevention & control | Cerebral Infarction - drug therapy | Infarction, Middle Cerebral Artery - physiopathology | Receptor, Bradykinin B2 - genetics | Bradykinin B1 Receptor Antagonists | Cerebrovascular Circulation - physiology | Gene Expression - drug effects | Infarction, Middle Cerebral Artery - metabolism | RNA, Messenger - metabolism | Cerebral Arteries - drug effects | Dose-Response Relationship, Drug | Receptor, Bradykinin B1 - genetics | Cerebral Infarction - physiopathology | Cerebral Infarction - metabolism | Encephalitis - physiopathology | Encephalitis - drug therapy | Gene Expression - physiology | Infarction, Middle Cerebral Artery - drug therapy | Bradykinin - pharmacology | Disease Models, Animal | RNA, Messenger - drug effects | Bradykinin - metabolism | Bradykinin - therapeutic use | Brain Edema - metabolism | Cerebrovascular Circulation - drug effects | Endothelin-1 - metabolism | Mice, Inbred C57BL | Cerebral Arteries - physiopathology | Bradykinin - antagonists & inhibitors | Bradykinin B2 Receptor Antagonists | Down-Regulation - genetics | Mice, Knockout | Animals | Brain Edema - physiopathology | Cerebral Arteries - metabolism | Receptor, Bradykinin B2 - metabolism | Brain Edema - drug therapy | Mice | Receptor, Bradykinin B1 - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Lanadelumab; Future plasma-independent subcutaneous prophylaxis for bradykinin-mediated angioedema?/Lanadelumab; Zukunftige plasmaunabhangige, subkutane Prophylaxe fur Bradykinin-vermittelte Angioodeme?
by Wedi, B
Der Hautarzt, ISSN 0017-8470, 07/2017, Volume 68, Issue 7, p. 585
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00105-017-3991-7 
Bradykinin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B.sub.2 receptor antagonist fasitibant
by Gomis, A and Meini, S and Miralles, A and Valenti, C and Giuliani, S and Belmonte, C and Maggi, C.A
Osteoarthritis and Cartilage, ISSN 1063-4584, 09/2013, Volume 21, Issue 9, p. 1346
The aim of this study was to determine in intact and inflamed knee joints of the rat, the effect of the bradykinin (BK) B.sub.2 receptor antagonist fasitibant... 
Bradykinin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Distribution of voltage-dependent and intracellular Ca super(2+) channels in submucosal neurons from rat distal colon
by Rehn, Matthias and Bader, Sandra and Bell, Anna and Diener, Martin
Cell and Tissue Research, ISSN 0302-766X, 09/2013, Volume 353, Issue 3, pp. 355 - 366
We recently observed a bradykinin-induced increase in the cytosolic Ca super(2+) concentration in submucosal neurons of rat colon, an increase inhibited by... 
Bradykinin
Journal Article
Details down arrow
8. Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes
by Potier, Louis and Waeckel, Ludovic and Vincent, Marie-Pascale and Chollet, Catherine and Gobeil Jr, Fernand and Marre, Michel and Bruneval, Patrick and Richer, Christine and Roussel, Ronan and Alhenc-Gelas, François and Bouby, Nadine
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 07/2013, Volume 346, Issue 1, pp. 23 - 30
Cardiac ischemia is a leading cause of death, especially in diabetic patients. The diabetic ischemic heart is resistant experimentally to established... 
INFARCT SIZE | TISSUE KALLIKREIN | ISCHEMIA/REPERFUSION INJURY | GLUCOSE CONTROL | BRADYKININ B-2 RECEPTORS | REPERFUSION INJURY | IN-VIVO | B2 RECEPTORS | PHARMACOLOGY & PHARMACY | B1 RECEPTOR | GENE KNOCKOUT MICE | Bradykinin - analogs & derivatives | Myocardial Ischemia - metabolism | Receptor, Bradykinin B2 - genetics | Receptor, Bradykinin B2 - agonists | Diabetes Mellitus, Type 1 - metabolism | Glycogen Synthase Kinase 3 beta | Male | Diabetes Mellitus, Type 1 - complications | Cardiotonic Agents - therapeutic use | Dose-Response Relationship, Drug | Receptor, Bradykinin B1 - agonists | Receptor, Bradykinin B1 - genetics | Protein Processing, Post-Translational - drug effects | Cardiotonic Agents - adverse effects | Myocardium - metabolism | Phosphorylation - drug effects | Drug Resistance | Bradykinin - therapeutic use | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Bradykinin - adverse effects | Mice, Inbred C57BL | Gene Expression Regulation | Glycogen Synthase Kinase 3 - metabolism | Myocardial Ischemia - drug therapy | Up-Regulation - drug effects | Animals | Cardiotonic Agents - administration & dosage | MAP Kinase Signaling System - drug effects | Myocardial Ischemia - complications | Receptor, Bradykinin B2 - metabolism | Mice | Receptor, Bradykinin B1 - metabolism | Bradykinin - administration & dosage | Myocardial Reperfusion Injury - prevention & control
Journal Article
Details down arrow
9. Full Text Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1/2 and PI3K/Akt pathways
by Nicoletti, Natália Fontana and Erig, Thaís Cristina and Zanin, Rafael Fernandes and Pereira, Talita Carneiro Brandão and Bogo, Mauricio Reis and Campos, Maria Martha and Morrone, Fernanda Bueno
Journal of Neuro-Oncology, ISSN 0167-594X, 11/2014, Volume 120, Issue 2, pp. 235 - 244
Gliomas are the most common malignant brain tumors in adults. Bradykinin (BK) displays an important role in cancer, although the exact role of kinin receptors... 
Neurology | Kinin receptors | Medicine & Public Health | Bradykinin | Glioblastoma | ERK1/2 signaling | Oncology | PI3K/Akt | PRIMARY BRAIN-TUMORS | MIGRATION | BRADYKININ RECEPTOR | CLINICAL NEUROLOGY | MALIGNANT GLIOMA | ONCOLOGY | INFLAMMATION | PROSTATE-CANCER CELLS | B-2 RECEPTORS | INHIBITORS | EXPRESSION | Bradykinin - analogs & derivatives | Receptor, Bradykinin B2 - genetics | Cell Proliferation | Humans | Phosphatidylinositol 3-Kinases - metabolism | Proto-Oncogene Proteins c-akt - genetics | Bradykinin B2 Receptor Antagonists - pharmacology | Glioma - metabolism | Receptor, Bradykinin B1 - genetics | Flow Cytometry | Glioma - pathology | Mitogen-Activated Protein Kinase 1 - genetics | Dioxoles - pharmacology | Phosphorylation - drug effects | Tumor Cells, Cultured | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Bradykinin - pharmacology | Mitogen-Activated Protein Kinase 3 - genetics | Bradykinin B1 Receptor Antagonists - pharmacology | RNA, Messenger - genetics | Receptor, Bradykinin B1 - chemistry | Receptor, Bradykinin B2 - chemistry | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Blotting, Western | Phosphatidylinositol 3-Kinases - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Receptor, Bradykinin B2 - metabolism | Receptor, Bradykinin B1 - metabolism | Glioma - drug therapy | Apoptosis | Mitogen-Activated Protein Kinase 1 - metabolism | RNA | Gliomas | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Bradykinin-Induced Microglial Migration Mediated by B1-Bradykinin Receptors Depends on Ca2+ Influx via Reverse-Mode Activity of the Na+/Ca2+ Exchanger
by Ifuku, Masataka and Farber, Katrin and Okuno, Yuko and Yamakawa, Yukiko and Miyamoto, Taiki and Nolte, Christiane and Merrino, Vanessa F and Kita, Satomi and Iwamoto, Takahiro and Komuro, Issei and Wang, Bing and Cheung, Giselle and Ishikawa, Eiichi and Ooboshi, Hiroaki and Bader, Michael and Wada, Keiji and Kettenmann, Helmut and Noda, Mami
Journal of Neuroscience, ISSN 0270-6474, 11/2007, Volume 27, Issue 48, pp. 13065 - 13073
Bradykinin (BK) is produced and acts at the site of injury and inflammation. In the CNS, migration of microglia toward the lesion site plays an important role... 
dependent K | current | Motility | Bradykinin | exchanger | Chemotaxis | Ca | Microglia | Bradykinin - analogs & derivatives | Receptor, Bradykinin B2 - agonists | Bradykinin B1 Receptor Antagonists | Rats, Wistar | Calcium - metabolism | Adenosine Triphosphate - pharmacology | Dose-Response Relationship, Drug | Receptor, Bradykinin B1 - agonists | Time Factors | Bradykinin - pharmacology | Animals, Newborn | Cerebellar Cortex - cytology | Microglia - drug effects | Cells, Cultured | Rats | Bradykinin B2 Receptor Antagonists | Chemotaxis - drug effects | Sodium-Calcium Exchanger - physiology | Mice, Knockout | Cell Movement - drug effects | Animals | Receptor, Bradykinin B1 - deficiency | Signal Transduction - drug effects | Receptor, Bradykinin B2 - deficiency | Receptor, Bradykinin B1 - physiology | Mice | Ca2+ exchanger | Ca2+-dependent K+ current | bradykinin | Na+ | motility | microglia | chemotaxis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Bifunctional ligands of the bradykinin B 2 and B 1 receptors: An exercise in peptide hormone plasticity
by Marceau, François and Bawolak, Marie-Thérèse and Fortin, Jean-Philippe and Morissette, Guillaume and Roy, Caroline and Bachelard, Hélène and Gera, Lajos and Charest-Morin, Xavier
Peptides, ISSN 0196-9781, 07/2018, Volume 105, pp. 37 - 50
Kinins are the small and fragile hydrophilic peptides related to bradykinin (BK) and derived from circulating kininogens via the action of kallikreins. Kinins... 
Biotechnological agents | Synthetic peptides | receptors | Bradykinin | Fluorescent ligands | HEREDITARY ANGIOEDEMA | PHARMACOLOGICAL CHARACTERIZATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | BETA-ARRESTIN | ANGIOTENSIN-CONVERTING-ENZYME | B-2 receptors | STEREOCHEMICAL REQUIREMENTS | B-1 receptors | IN-VIVO | ENDOCRINOLOGY & METABOLISM | PHARMACOLOGY & PHARMACY | AMINOPEPTIDASE-N | B2 RECEPTOR | PROTEIN-COUPLED-RECEPTOR | CANCER CELL-LINES | Bradykinin - analogs & derivatives | Bradykinin - metabolism | Bradykinin - chemistry | Bradykinin B1 Receptor Antagonists - pharmacology | Humans | Receptor, Bradykinin B1 - chemistry | Receptor, Bradykinin B2 - chemistry | Structure-Activity Relationship | DNA-(Apurinic or Apyrimidinic Site) Lyase - chemistry | DNA-(Apurinic or Apyrimidinic Site) Lyase - metabolism | Receptor, Bradykinin B2 - metabolism | Ligands | Peptide Hormones - chemistry | Receptor, Bradykinin B1 - metabolism | Bradykinin - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice
by Rodrigues-Junior, Valnês S and Pail, Priscilla B and Villela, Anne D and Falcão, Virgínia C.A and Dadda, Adílio S and Abbadi, Bruno L and Pesquero, João B and Santos, Diógenes S and Basso, Luiz A and Campos, Maria M
Tuberculosis, ISSN 1472-9792, 03/2018, Volume 109, pp. 1 - 7
The role, if any, played by the kinin system in tuberculosis infection models, either or , was investigated. The effects of infection on C57BL/6 wild type, B... 
Tuberculosis | Kinin receptors | Drug development | SSR240612 | KININ B-1 RECEPTORS | PATHWAYS | TRYPANOSOMA-CRUZI | COMPOUND | INJURY | MICROBIOLOGY | IMMUNOLOGY | MURINE MODEL | IQG-607 | CONVERTING ENZYME-INHIBITION | RESPIRATORY SYSTEM | DISEASE | EXPRESSION | Bradykinin - analogs & derivatives | Lung - microbiology | Receptor, Bradykinin B2 - genetics | Tuberculosis, Pulmonary - microbiology | Receptor, Bradykinin B1 - drug effects | Tuberculosis, Pulmonary - metabolism | Bradykinin B2 Receptor Antagonists - administration & dosage | Male | Tuberculosis, Pulmonary - drug therapy | Spleen - drug effects | Tuberculosis, Pulmonary - genetics | Mycobacterium tuberculosis - drug effects | Spleen - microbiology | Receptor, Bradykinin B1 - genetics | Dioxoles - administration & dosage | Female | Lung - metabolism | Macrophages - microbiology | Disease Models, Animal | Administration, Oral | Mice, Inbred C57BL | Bacterial Load | Mice, Knockout | Macrophages - metabolism | Animals | Receptor, Bradykinin B1 - deficiency | Spleen - metabolism | Lung - drug effects | Antitubercular Agents - administration & dosage | Receptor, Bradykinin B2 - metabolism | Macrophages - drug effects | RAW 264.7 Cells | Bradykinin B1 Receptor Antagonists - administration & dosage | Mice | Receptor, Bradykinin B1 - metabolism | Bradykinin - administration & dosage | Sulfonamides - administration & dosage | Mycobacterium tuberculosis - growth & development | Animal experimentation | Immunohistochemistry | Bradykinin | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Hypoxic remodelling of Ca.sup.2+ stores does not alter human cardiac myofibroblast invasion
by Riches, K and Hettiarachchi, N.T and Porter, K.E and Peers, C
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 12/2010, Volume 403, Issue 3-4, p. 468
a* Bradykinin promotes migration and proliferation of myofibroblasts. a* Such activity is Ca.sup.2+-dependent and occurs under hypoxic conditions. a* Hypoxia... 
Bradykinin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Trisk 32 regulates IP sub(3) receptors in rat skeletal myoblasts
by Olah, Tamas and Fodor, Janos and Oddoux, Sarah and Ruzsnavszky, Olga and Marty, Isabelle and Csernoch, Laszlo
Pfluegers Archiv/European Journal of Physiology, ISSN 0031-6768, 10/2011, Volume 462, Issue 4, pp. 599 - 610
To date, four isoforms of triadins have been identified in rat skeletal muscle. While the function of the 95-kDa isoform in excitation-contraction coupling has... 
Bradykinin
Journal Article
Details down arrow
15. Full Text A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema
by Baş, Murat and Greve, Jens and Stelter, Klaus and Havel, Miriam and Strassen, Ulrich and Rotter, Nicole and Veit, Johannes and Schossow, Beate and Hapfelmeier, Alexander and Kehl, Victoria and Kojda, Georg and Hoffmann, Thomas K
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 418 - 425
Thirty patients with ACE-inhibitor–induced angioedema were assigned to receive icatibant or standard therapy with intravenous prednisolone plus clemastine. The... 
BRADYKININ-RECEPTOR ANTAGONIST | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CONVERTING-ENZYME-INHIBITOR | EDEMA | RISK | MEDIATED ANGIOEDEMA | ANGIOTENSIN | Bradykinin - analogs & derivatives | Glucocorticoids - therapeutic use | Bradykinin - therapeutic use | Double-Blind Method | Bradykinin - adverse effects | Humans | Middle Aged | Male | Injections, Subcutaneous - adverse effects | Bradykinin B2 Receptor Antagonists - therapeutic use | Angioedema - drug therapy | Bradykinin B2 Receptor Antagonists - adverse effects | Histamine H1 Antagonists - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Angioedema - chemically induced | Female | Aged | Prednisolone - therapeutic use | Clemastine - therapeutic use | Drug Therapy, Combination | Edema | Intravenous administration | Glucocorticoids | Angioedema | Clinical trials | Patients | Inflammatory diseases | Respiratory tract | Side effects | Antagonist drugs | Bradykinin | Angiotensin | Head and neck | Neck | Drug therapy | ACE inhibitors | Prednisolone | Enzymes | Statistical analysis | Otolaryngology | Emergency medical care | Studies | Histamine | Larynx | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Role of Kinin B2 Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential
by Kränkel, Nicolle and Katare, Rajesh G and Siragusa, Mauro and Barcelos, Luciola S and Campagnolo, Paola and Mangialardi, Giuseppe and Fortunato, Orazio and Spinetti, Gaia and Tran, Nguyen and Zacharowski, Kai and Wojakowski, Wojciech and Mroz, Iwona and Herman, Andrew and Manning Fox, Jocelyn E and MacDonald, Patrick E and Schanstra, Joost P and Bascands, Jean Loup and Ascione, Raimondo and Angelini, Gianni and Emanueli, Costanza and Madeddu, Paolo
Circulation Research, ISSN 0009-7330, 11/2008, Volume 103, Issue 11, pp. 1335 - 1343
Reduced migratory function of circulating angiogenic progenitor cells (CPCs) has been associated with impaired neovascularization in patients with... 
Angiogenesis | Progenitor recruitment | Therapeutic neovascularization | Bradykinin | Migration | Bradykinin - analogs & derivatives | Cell- and Tissue-Based Therapy - methods | Receptor, Bradykinin B2 - genetics | Angina Pectoris - physiopathology | Humans | Myocardial Revascularization - methods | Stem Cells - cytology | Myocardial Infarction - therapy | Flow Cytometry | Leukocytes, Mononuclear - physiology | Leukocytes, Mononuclear - transplantation | Myocardial Infarction - physiopathology | Adrenergic beta-Agonists - therapeutic use | Bradykinin - therapeutic use | Receptor, Bradykinin B2 - physiology | Mice, Knockout | Neovascularization, Physiologic - physiology | Stem Cell Transplantation - methods | Animals | Receptor, Bradykinin B2 - deficiency | Myocardial Ischemia - therapy | Stem Cells - physiology | Mice | Receptor, Bradykinin B2 - drug effects | Cell Movement | Tissue Therapy | Angina Pectoris | Leukocytes, Mononuclear | Myocardial Ischemia | Myocardial Revascularization | Stem Cell Transplantation | Stem Cells | Adrenergic beta-Agonists | Myocardial Infarction | Receptor, Bradykinin B2 | Neovascularization, Physiologic | bradykinin | migration | progenitor recruitment | angiogenesis | therapeutic neovascularization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
by Cicardi, M and Bork, K and Caballero, T and Craig, T and Li, H. H and Longhurst, H and Reshef, A and Zuraw, B and Hawk Hereditary Angioedema Int Wo and HAWK (Hereditary Angioedema International Working Group)
Allergy, ISSN 0105-4538, 02/2012, Volume 67, Issue 2, pp. 147 - 157
Angioedema owing to hereditary deficiency of C1 inhibitor (HAE) is a rare, life-threatening, disabling disease. In the last 2 years, the results of... 
C1 inhibitor | hereditary angioedema | bradykinin receptor antagonist | consensus document | kallikrein inhibitor | ACUTE ATTACKS | C1-INHIBITOR CONCENTRATE | IMMUNOLOGY | DANAZOL PROPHYLAXIS | EVIDENCE-BASED MEDICINE | ATTENUATED ANDROGENS | LONG-TERM PROPHYLAXIS | ECALLANTIDE TREATMENT | ALLERGY | DOUBLE-BLIND | ESTERASE INHIBITOR | Bradykinin - analogs & derivatives | Complement C1 Inhibitor Protein - therapeutic use | Bradykinin - therapeutic use | Kallikreins - antagonists & inhibitors | Bradykinin - adverse effects | Humans | Angioedemas, Hereditary - therapy | Peptides - administration & dosage | Complement C1 Inhibitor Protein - adverse effects | Complement C1 Inactivator Proteins - deficiency | Bradykinin Receptor Antagonists | Complement C1 Inhibitor Protein - administration & dosage | Bradykinin - administration & dosage | Peptides - adverse effects | Peptides - therapeutic use | Adolescence | angioedema | Conferences | complement component C1 | Hypersensitivity | Clinical trials | Pharmaceuticals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights